Literature DB >> 20044576

O-mannosyl phosphorylation of alpha-dystroglycan is required for laminin binding.

Takako Yoshida-Moriguchi1, Liping Yu, Stephanie H Stalnaker, Sarah Davis, Stefan Kunz, Michael Madson, Michael B A Oldstone, Harry Schachter, Lance Wells, Kevin P Campbell.   

Abstract

Alpha-dystroglycan (alpha-DG) is a cell-surface glycoprotein that acts as a receptor for both extracellular matrix proteins containing laminin-G domains and certain arenaviruses. Receptor binding is thought to be mediated by a posttranslational modification, and defective binding with laminin underlies a subclass of congenital muscular dystrophy. Using mass spectrometry- and nuclear magnetic resonance (NMR)-based structural analyses, we identified a phosphorylated O-mannosyl glycan on the mucin-like domain of recombinant alpha-DG, which was required for laminin binding. We demonstrated that patients with muscle-eye-brain disease and Fukuyama congenital muscular dystrophy, as well as mice with myodystrophy, commonly have defects in a postphosphoryl modification of this phosphorylated O-linked mannose, and that this modification is mediated by the like-acetylglucosaminyltransferase (LARGE) protein. These findings expand our understanding of the mechanisms that underlie congenital muscular dystrophy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20044576      PMCID: PMC2978000          DOI: 10.1126/science.1180512

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  24 in total

1.  Molecular recognition by LARGE is essential for expression of functional dystroglycan.

Authors:  Motoi Kanagawa; Fumiaki Saito; Stefan Kunz; Takako Yoshida-Moriguchi; Rita Barresi; Yvonne M Kobayashi; John Muschler; Jan P Dumanski; Daniel E Michele; Michael B A Oldstone; Kevin P Campbell
Journal:  Cell       Date:  2004-06-25       Impact factor: 41.582

2.  Mutant glycosyltransferase and altered glycosylation of alpha-dystroglycan in the myodystrophy mouse.

Authors:  P K Grewal; P J Holzfeind; R E Bittner; J E Hewitt
Journal:  Nat Genet       Date:  2001-06       Impact factor: 38.330

3.  New World arenavirus clade C, but not clade A and B viruses, utilizes alpha-dystroglycan as its major receptor.

Authors:  Christina F Spiropoulou; Stefan Kunz; Pierre E Rollin; Kevin P Campbell; Michael B A Oldstone
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

4.  Muscular dystrophy and neuronal migration disorder caused by mutations in a glycosyltransferase, POMGnT1.

Authors:  A Yoshida; K Kobayashi; H Manya; K Taniguchi; H Kano; M Mizuno; T Inazu; H Mitsuhashi; S Takahashi; M Takeuchi; R Herrmann; V Straub; B Talim; T Voit; H Topaloglu; T Toda; T Endo
Journal:  Dev Cell       Date:  2001-11       Impact factor: 12.270

5.  Post-translational disruption of dystroglycan-ligand interactions in congenital muscular dystrophies.

Authors:  Daniel E Michele; Rita Barresi; Motoi Kanagawa; Fumiaki Saito; Ronald D Cohn; Jakob S Satz; James Dollar; Ichizo Nishino; Richard I Kelley; Hannu Somer; Volker Straub; Katherine D Mathews; Steven A Moore; Kevin P Campbell
Journal:  Nature       Date:  2002-07-25       Impact factor: 49.962

6.  Mutations in the human LARGE gene cause MDC1D, a novel form of congenital muscular dystrophy with severe mental retardation and abnormal glycosylation of alpha-dystroglycan.

Authors:  Cheryl Longman; Martin Brockington; Silvia Torelli; Cecilia Jimenez-Mallebrera; Colin Kennedy; Nofal Khalil; Lucy Feng; Ravindra K Saran; Thomas Voit; Luciano Merlini; Caroline A Sewry; Susan C Brown; Francesco Muntoni
Journal:  Hum Mol Genet       Date:  2003-09-09       Impact factor: 6.150

7.  LARGE can functionally bypass alpha-dystroglycan glycosylation defects in distinct congenital muscular dystrophies.

Authors:  Rita Barresi; Daniel E Michele; Motoi Kanagawa; Hollie A Harper; Sherri A Dovico; Jakob S Satz; Steven A Moore; Wenli Zhang; Harry Schachter; Jan P Dumanski; Ronald D Cohn; Ichizo Nishino; Kevin P Campbell
Journal:  Nat Med       Date:  2004-06-06       Impact factor: 53.440

8.  Mutations in the O-mannosyltransferase gene POMT1 give rise to the severe neuronal migration disorder Walker-Warburg syndrome.

Authors:  Daniel Beltrán-Valero de Bernabé; Sophie Currier; Alice Steinbrecher; Jacopo Celli; Ellen van Beusekom; Bert van der Zwaag; Hülya Kayserili; Luciano Merlini; David Chitayat; William B Dobyns; Bru Cormand; Ana-Elina Lehesjoki; Jesús Cruces; Thomas Voit; Christopher A Walsh; Hans van Bokhoven; Han G Brunner
Journal:  Am J Hum Genet       Date:  2002-10-04       Impact factor: 11.025

9.  Demonstration of mammalian protein O-mannosyltransferase activity: coexpression of POMT1 and POMT2 required for enzymatic activity.

Authors:  Hiroshi Manya; Atsuro Chiba; Aruto Yoshida; Xiaohui Wang; Yasunori Chiba; Yoshifumi Jigami; Richard U Margolis; Tamao Endo
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-29       Impact factor: 11.205

10.  Molecular analysis of the interaction of LCMV with its cellular receptor [alpha]-dystroglycan.

Authors:  S Kunz; N Sevilla; D B McGavern; K P Campbell; M B Oldstone
Journal:  J Cell Biol       Date:  2001-10-15       Impact factor: 10.539

View more
  161 in total

1.  Differential glycosylation of α-dystroglycan and proteins other than α-dystroglycan by like-glycosyltransferase.

Authors:  Peng Zhang; Huaiyu Hu
Journal:  Glycobiology       Date:  2011-09-19       Impact factor: 4.313

2.  Neurology of inherited glycosylation disorders.

Authors:  Hudson H Freeze; Erik A Eklund; Bobby G Ng; Marc C Patterson
Journal:  Lancet Neurol       Date:  2012-05       Impact factor: 44.182

3.  Like-acetylglucosaminyltransferase (LARGE)-dependent modification of dystroglycan at Thr-317/319 is required for laminin binding and arenavirus infection.

Authors:  Yuji Hara; Motoi Kanagawa; Stefan Kunz; Takako Yoshida-Moriguchi; Jakob S Satz; Yvonne M Kobayashi; Zihan Zhu; Steven J Burden; Michael B A Oldstone; Kevin P Campbell
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-10       Impact factor: 11.205

4.  RPTPζ/phosphacan is abnormally glycosylated in a model of muscle-eye-brain disease lacking functional POMGnT1.

Authors:  C A Dwyer; E Baker; H Hu; R T Matthews
Journal:  Neuroscience       Date:  2012-06-19       Impact factor: 3.590

Review 5.  Vertebrate protein glycosylation: diversity, synthesis and function.

Authors:  Kelley W Moremen; Michael Tiemeyer; Alison V Nairn
Journal:  Nat Rev Mol Cell Biol       Date:  2012-06-22       Impact factor: 94.444

6.  Site mapping and characterization of O-glycan structures on alpha-dystroglycan isolated from rabbit skeletal muscle.

Authors:  Stephanie H Stalnaker; Sana Hashmi; Jae-Min Lim; Kazuhiro Aoki; Mindy Porterfield; Gerardo Gutierrez-Sanchez; James Wheeler; James M Ervasti; Carl Bergmann; Michael Tiemeyer; Lance Wells
Journal:  J Biol Chem       Date:  2010-05-27       Impact factor: 5.157

7.  Mammalian O-mannosylation of cadherins and plexins is independent of protein O-mannosyltransferases 1 and 2.

Authors:  Ida Signe Bohse Larsen; Yoshiki Narimatsu; Hiren Jitendra Joshi; Zhang Yang; Oliver J Harrison; Julia Brasch; Lawrence Shapiro; Barry Honig; Sergey Y Vakhrushev; Henrik Clausen; Adnan Halim
Journal:  J Biol Chem       Date:  2017-05-16       Impact factor: 5.157

Review 8.  Understanding human glycosylation disorders: biochemistry leads the charge.

Authors:  Hudson H Freeze
Journal:  J Biol Chem       Date:  2013-01-17       Impact factor: 5.157

Review 9.  The challenge and promise of glycomics.

Authors:  Richard D Cummings; J Michael Pierce
Journal:  Chem Biol       Date:  2014-01-16

10.  Alterations of dystrophin-associated glycoproteins in the heart lacking dystrophin or dystrophin and utrophin.

Authors:  Katharine M Sharpe; Monica D Premsukh; DeWayne Townsend
Journal:  J Muscle Res Cell Motil       Date:  2013-10-06       Impact factor: 2.698

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.